Quantinno Capital Management’s Amneal Pharmaceuticals AMRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.06M Sell
201,561
-7,469
-4% -$135K ﹤0.01% 1608
2026
Q2
$3.62M Buy
209,030
+171,431
+456% +$2.35M ﹤0.01% 1497
2026
Q1
$467K Buy
37,599
+10,457
+39% +$140K ﹤0.01% 2759
2025
Q4
$342K Buy
27,142
+4,460
+20% +$51K ﹤0.01% 2744
2025
Q3
$227K Buy
22,682
+9,583
+73% +$86K ﹤0.01% 2675
2025
Q2
$106K Buy
+13,099
New +$98.8K ﹤0.01% 2503

Other funds holding AMRX

Quantinno Capital Management's AMRX Position: Q3 2026 in Review

Quantinno Capital Management reduced its Amneal Pharmaceuticals (AMRX) stake by 3.6% in Q3 2026, selling an estimated $135K and leaving 201,561 shares worth $4.06M. The position accounts for ﹤0.01% of the portfolio, ranked #1608.

Quantinno Capital Management first reported a position in AMRX in Q2 2025 and has held it in 6 quarters since. 334 funds tracked by Wall St. Rank hold AMRX as of Q3 2026.

  • Quantinno Capital Management held 201,561 shares of Amneal Pharmaceuticals worth $4.06M as of Q3 2026.
  • Quantinno Capital Management sold 7,469 Amneal Pharmaceuticals shares in Q3 2026, an estimated $135K.
  • Amneal Pharmaceuticals made up ﹤0.01% of Quantinno Capital Management's portfolio in Q3 2026, its #1608 holding.
  • Quantinno Capital Management first reported a position in Amneal Pharmaceuticals in Q2 2025 and has held it in 6 quarters since.
  • 334 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q3 2026.

Based on Quantinno Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.